Source: BioSpace

Bolder Biopath: Sinclair Research Announces Strategic Partnership with Bolder BioPATH to Expand Early-stage Discovery Model Portfolio

Sinclair Research, a leading provider of nonclinical contract research services, today announced a strategic partnership with Bolder BioPATH, a premier provider of pharmacology and pathology services specializing in in vivo models of Rheumatoid Arthritis, Osteoarthritis, Inflammatory Bowel Disease, and other autoimmune and inflammation models. "Bolder BioPATH has developed a portfolio of high-quality pharmacology mode

Read full article »
Est. Annual Revenue
$5.0-25M
Est. Employees
25-100
Phillip Bendele's photo - CEO of Bolder BioPATH

CEO

Phillip Bendele

CEO Approval Rating

90/100

Read more